Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Epilepsy and seizure classification

Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet.

Maria Dahlin; Stephanie S Singleton; John A David; Atin Basuchoudhary; Ronny Wickström; Raja Mazumder; Stefanie Prast-Nielsen

Originally published in EBioMedicine · 2022-05-19

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Background Recently, studies have suggested a role for the gut microbiota in epilepsy. Gut microbial changes during ketogenic diet (KD) treatment of drug-resistant epilepsy have been described. Inflammation is associated with certain types of epilepsy and specific inflammation markers decrease during KD. The gut microbiota plays an important role in the regulation of the immune system and inflammation. Methods 28 children with drug-resistant epilepsy treated with the ketogenic diet were followed in this observational study. Fecal and serum samples were collected at baseline and three months after dietary intervention. Findings We identified both gut microbial and inflammatory changes during treatment. KD had a general anti-inflammatory effect. Novel bioinformatics and machine learning approaches identified signatures of specific Bifidobacteria and TNF (tumor necrosis factor) associated with responders before starting KD. During KD, taxonomic and inflammatory profiles between responders and non-responders were more similar than at baseline.

Results

The study included 28 children with pharmaco-resistant epilepsy treated with the KD. For inclusion and exclusion criteria of the patients, demographics, and treatment details, see Methods and Table 1. Fecal samples as well as blood samples were collected at two time points, before and three months after initiation of KD. At the second time point the mean ketogenic ratio for the 28 patients was 3.4 ± 0.5 (mean ± SD) and the ratio was 4:1 in eight children, 3.5:1 in eleven, 3:1 in eight and 2:1 in one.

Discussion

In a previously published pilot study, we identified E. coli and Bifidobacteria as the main taxa influenced by KD treatment of children with drug-resistant epilepsy.11 Here, we could confirm these signatures in a larger cohort. Albeit using a different approach for taxonomic profiling and analyses, including machine learning, these taxa were identified among others as important drivers of microbial changes during KD. Our new approach enabled higher resolution at species and strain level. Changes in relative abundance of several E.

Editorial reading guide

  • Which patient population and reference standard did the authors use?
  • Was the finding validated in a separate cohort, and how might patient selection affect it?